Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -4,043 | -3,698 | -1,674 |
| Depreciation Amortization | N/A | 753 | 607 | 201 |
| Other Working Capital | N/A | 893 | 237 | -27 |
| Other Operating Activity | 0 | 24 | 0 | 0 |
| Operating Cash Flow | $N/A | $-2,372 | $-2,854 | $-1,500 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -289 | -813 | -877 |
| Other Investing Activity | 0 | 10 | 0 | 0 |
| Investing Cash Flow | $N/A | $-278 | $-813 | $-877 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 7,662 | -235 | 9,960 |
| Financing Cash Flow | $N/A | $7,662 | $-235 | $9,960 |
| Beginning Cash Position | N/A | 5,301 | 9,203 | 1,621 |
| End Cash Position | N/A | 10,312 | 5,301 | 9,203 |
| Net Cash Flow | $N/A | $5,011 | $-3,902 | $7,583 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | -2,372 | -2,854 | -1,500 |
| Free Cash Flow | 0 | -2,372 | -2,854 | -1,500 |